SEC Form 4 · accession 0001127602-19-009899
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Gallina
Officer — EVP & Chief Financial Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | F | 2,217 | $307.68 | D | 13,442 | D | |
| Common StockF2 | Mar 1, 2019 | A | 2,940 | $0.00 | A | 16,382 | D | |
| Common StockF3 | Mar 1, 2019 | A | 2,641 | $0.00 | A | 19,023 | D | |
| Common StockF4 | Mar 1, 2019 | A | 4,033 | $0.00 | A | 23,056 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $307.68 | Mar 1, 2019 | A | 12,187 | A | — | Mar 1, 2029 | Common Stock | 12,187 | 12,187 | D |
Explanation of responses
- F1PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- F2Represents performance based restricted share units. Restrictions lapse on 3/1/19.
- F3Represents restricted share units. Restrictions lapse as follows: 880 shares each on 3/1/2020 and 3/1/2021, and 881 on 3/1/2022.
- F4Represents performance based restricted share units. Restrictions lapse on 6/1/19.
- F5The option represents a right to purchase a total of 12,187 shares, and is exercisable in three annual installments, with two installments of 4,062 shares each and one installment of 4,063 shares, beginning on 3/1/2020, which is the one-year anniversary of the option grant date.